Latest Form 4 insider transactions

NASDAQ
Zvi Alon, CEO / Chairperson, a Director and 10% owner of Tigo Energy, Inc., reported multiple transactions in common stock on August 7, 2026.
NASDAQ
Yahui Chang, Chief Operating Officer of Tigo Energy, Inc., received 62,700 shares of common stock on August 7, 2026.
NASDAQ
Bill Roeschlein, Chief Financial Officer of Tigo Energy, Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Charles R. Schwab, Co-Chairman and a Director of Schwab Charles Corp, sold 46,445 shares of common stock on August 11, 2026 for $107.78 per share.
NYSE
Ldb 2014 Llc reported changes in beneficial ownership of Apollo Global Management, Inc. common stock on July 29, 2026.
NYSE
Leon D Black, See remarks. of Apollo Global Management, Inc., reported a transaction in 1 shares of common stock on August 7, 2026.
NYSE
David N Capobianco, a Director and 10% owner of LandBridge Co LLC, sold 1,250,000 shares of common stock on August 7, 2026 for $75.05 per share.
NYSE
Gregory S Marcus, President and CEO and a Director of Marcus Corp, reported a transaction in 1,249 shares of common stock on August 7, 2026.
NYSE
David John Marcus, a Director of Marcus Corp, reported a transaction in 1,249 shares of common stock on August 7, 2026.
NYSE
David Marcus, a Director of Nu Holdings Ltd., received 25,290 shares of common stock on August 7, 2026.
NYSE
David S Buzby, a Director of Stem, Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Krishna Shivram, a Director of Stem, Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Adam Daley, a Director of Stem, Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Anil Tammineedi, a Director of Stem, Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Vasudevan Guruswamy, a Director of Stem, Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Laura D Tyson, a Director of Stem, Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Ira M Birns, a Director of Stem, Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Jacqueline D Reses, a Director of Nu Holdings Ltd., received 27,096 shares of common stock on August 7, 2026.
NYSE
Diego Piacentini, a Director of Nu Holdings Ltd., received 23,483 shares of common stock on August 7, 2026.
NYSE
Anita M Sands, a Director of Nu Holdings Ltd., received 30,709 shares of common stock on August 7, 2026.
NASDAQ
Kenneth D. Eichenbaum, a Director of Femasys Inc, received 880 shares of common stock on June 24, 2026.
NYSE
Douglas M Leone, a Director of Nu Holdings Ltd., received 25,290 shares of common stock on August 7, 2026.
NASDAQ
Edward R Uzialko, a Director of Femasys Inc, received 880 shares of common stock on June 24, 2026.
NASDAQ
Alistair Milnes, a Director of Femasys Inc, received 880 shares of common stock on June 24, 2026.
NASDAQ
Charles Larsen, a Director of Femasys Inc, received 880 shares of common stock on June 24, 2026.
NASDAQ
Ori Gutwerg, SVP, GENERICS of Ani Pharmaceuticals Inc, sold 3,162 shares of common stock on August 10, 2026 for $77.00 per share.
NASDAQ
Jeffrey Gerald Mifek, Chief Clinical-Medical Affairs of Femasys Inc, purchased 3,125 shares of common stock on August 7, 2026 for $3.20 per share.
NASDAQ
Jeffrey Gerald Mifek, Chief Clinical-Medical Affairs of Femasys Inc, received 6,250 shares of common stock on July 6, 2026.
NYSE
Mejia Luis Alberto Moreno, a Director of Nu Holdings Ltd., received 25,290 shares of common stock on August 7, 2026.
NASDAQ
Brin Sergey, a Director and 10% owner of Alphabet Inc., reported multiple transactions in common stock on August 7, 2026.